Related Experiment Video
Updated: May 2, 2026
Author Spotlight: High-Throughput Screening of CAR T-Cell Constructs for Enhanced Cytotoxicity and Immunologic Memory
Published on: October 27, 2023
Bcl-2 knockdown accelerates T cell receptor-triggered activation-induced cell death in jurkat T cells
Yun-Jung Lee1, Tae Joon Won1, Kyeong Eun Hyung1
1Laboratory of Host Defense Modulation, College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea.
Abstract:
Cell death and survival are tightly controlled through the highly coordinated activation/inhibition of diverse signal transduction pathways to insure normal development and physiology. Imbalance between cell death and survival often leads to autoimmune diseases and cancer. Death receptors sense extracellular signals to induce caspase-mediated apoptosis. Acting upstream of CED-3 family proteases, such as caspase-3, Bcl-2 prevents apoptosis. Using short hairpin RNAs (shRNAs), we suppressed Bcl-2 expression in Jurkat T cells, and this increased TCR-triggered AICD and enhanced TNFR gene expression. Also, knockdown of Bcl-2 in Jurkat T cells suppressed the gene expression of FLIP, TNF receptor-associated factors 3 (TRAF3) and TRAF4. Furthermore, suppressed Bcl-2 expression increased caspase-3 and diminished nuclear factor kappa B (NF-κB) translocation.
Insights
Suppressing Bcl-2 in T cells enhances T-cell receptor-induced cell death (AICD) and alters gene expression. This manipulation impacts apoptosis regulators and nuclear factor kappa B (NF-κB) signaling.
Area of Science:
- Cellular biology
- Immunology
- Molecular biology
Background:
- Cell death and survival pathways are crucial for normal physiology, and their dysregulation is linked to diseases like cancer and autoimmune disorders.
- Apoptosis, a programmed cell death, is tightly regulated by proteins such as Bcl-2, which inhibits caspases, and death receptors initiating the process.
Purpose of the Study:
- To investigate the role of Bcl-2 in regulating T-cell activation-induced cell death (AICD) and associated signaling pathways in Jurkat T cells.
- To determine the effect of Bcl-2 suppression on the expression of key genes involved in apoptosis and immune signaling.
Main Methods:
- Utilized short hairpin RNAs (shRNAs) to suppress Bcl-2 expression in Jurkat T cells.
- Analyzed changes in TCR-triggered AICD, gene expression (TNFR, FLIP, TRAF3, TRAF4), caspase-3 activity, and NF-κB translocation.
Main Results:
- Bcl-2 knockdown in Jurkat T cells led to increased TCR-triggered AICD.
- Suppression of Bcl-2 enhanced tumor necrosis factor receptor (TNFR) gene expression.
- Knockdown of Bcl-2 resulted in decreased expression of FLIP, TRAF3, and TRAF4, alongside increased caspase-3 activity and diminished NF-κB translocation.
Conclusions:
- Bcl-2 plays a significant inhibitory role in TCR-induced apoptosis in T cells.
- Modulating Bcl-2 levels impacts multiple signaling pathways, including those involving TNFR, FLIP, TRAF, and NF-κB, offering potential therapeutic targets.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:22T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
01:17The Extrinsic Apoptotic Pathway
01:15Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
01:11Cellular Injury IlI: Cellular Death